Protocol No.: COG-ANBL2131
- Title
- A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
- Principal Investigator
- Meyer, Ashley
- Phase
- III
- Age Group
- Children
- Participating Institutions
- Mary Babb Randolph Cancer Center
- West Virginia University
- Contact
- Abby Swiger, RN
- Research Nurse
- Phone: +1 304-293-1683
- Email: aswiger3@hsc.wvu.edu